Terms ending in 2039
Every in-force patent on Jazz Pharmaceuticals, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,413,264 | Carbamoyl Phenylalaninol Analogs and Uses Thereof In force · High confidence | Axsome Malta Ltd. | In force | High confidence | |
| US 11,456,081 | Sensitive Drug Distribution Systems and Methods In force · High confidence | Jazz Pharmaceuticals, Inc. | In force | High confidence | |
| US 11,571,440 | Defibrotide for the Prevention and Treatment of Cytokine Release Syndrome and Neurotoxicity Associated with Immunodepletion Richardson, Paul G. In force · High confidence | Richardson, Paul G. | In force | High confidence | |
| US 11,400,052 | Alcohol-Resistant Drug Formulations In force · High confidence | Jazz Pharmaceuticals Ireland Limited | In force | High confidence | |
| US 12,440,449 | Alcohol-Resistant Drug Formulations In force · High confidence | Jazz Pharmaceuticals Ireland Limited | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Jazz Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.